Maria Nichol

Maria Nichol has over 20 years of experience in the biotechnology industry. In 2021, they joined Fibrocor Therapeutics as a Non Executive Board Member. In 2022, they joined Compass IP Limited as a Consultant and Managing Director, and Agomab Therapeutics as Head of IP. Previously, Maria worked at Galapagos from 2006 to 2021 as a Consultant - IP, BD and Vice President, IP. From 2016 to 2021, they were a K2 Network Attorney at K2 IP Ltd. From 2003 to 2021, they were the IP Manager at Biotica Technology Limited and a Patent Associate at Oxford Glycosciences from 2003 to 2006.

Maria Nichol began their education in 1994 at the University of Cambridge, where they earned a BA Hons in Natural Science. Maria then attended the University of Oxford from 1997 to 2001, where they obtained a DPhil in Alzheimer's disease. From 2003 to 2007, Maria Nichol completed CIPA / EQE training, though no degree or field of study was specified.